These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 7777098)

  • 1. Effect of 1,25-dihydroxyvitamin D on the immune activity of peritoneal macrophages in continuous ambulatory peritoneal dialysis patients.
    Shany S; Levy R; Chaimovitz C
    Nephron; 1995; 69(4):367-70. PubMed ID: 7777098
    [No Abstract]   [Full Text] [Related]  

  • 2. Regulation of TNF-alpha by 1alpha,25-dihydroxyvitamin D3 in human macrophages from CAPD patients.
    Cohen ML; Douvdevani A; Chaimovitz C; Shany S
    Kidney Int; 2001 Jan; 59(1):69-75. PubMed ID: 11135059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zinc modulates mononuclear cellular calcitriol metabolism in peritoneal dialysis patients.
    Kimmel PL; Phillips TM; Lew SQ; Langman CB
    Kidney Int; 1996 May; 49(5):1407-12. PubMed ID: 8731107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peritonitis induces the synthesis of 1 alpha,25-dihydroxyvitamin D3 in macrophages from CAPD patients.
    Hayes ME; O'Donoghue DJ; Ballardie FW; Mawer EB
    FEBS Lett; 1987 Aug; 220(2):307-10. PubMed ID: 3609325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peritoneal macrophage and lymphocyte cytoplasmic Ca2+: effects on peritoneal immune defense mechanisms and ultrafiltration capacity in continuous ambulatory peritoneal dialysis.
    Carozzi S; Nasini MG; Pietrucci A; Santoni O; Schelotto C; Caviglia PM
    Perit Dial Int; 1993; 13 Suppl 2():S286-90. PubMed ID: 8399590
    [No Abstract]   [Full Text] [Related]  

  • 6. 1,25-Dihydroxycholecalciferol and peritoneal macrophage chemotaxis in patients on continuous ambulatory peritoneal dialysis.
    Chan PC; Ip MS; Pun KK
    Nephron; 1991; 59(3):434-9. PubMed ID: 1758534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The peritoneal immune system and continuous ambulatory peritoneal dialysis.
    Rapoport J; Hausmann MJ; Chaimovitz C
    Nephron; 1999; 81(4):373-80. PubMed ID: 10357643
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of peritoneal dialysis fluids on leukocyte function.
    Jörres A; Gahl GM
    Perit Dial Int; 1994; 14 Suppl 3():S29-32. PubMed ID: 7948271
    [No Abstract]   [Full Text] [Related]  

  • 9. Activation in vitro of peritoneal macrophages by a nocardia fraction.
    Ben-Efraim S; Rashid G; Gittel H; Tax C; Ciorbaru RB
    Anticancer Res; 1994; 14(2A):449-52. PubMed ID: 8017846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of 24,25-dihydroxyvitamin D levels in patients treated with continuous ambulatory peritoneal dialysis.
    Shany S; Rapoport J; Zuili I; Yankowitz N; Chaimovitz C
    Nephron; 1986; 42(2):141-5. PubMed ID: 3003603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of ionized calcium and 1,25-dihydroxycholecalciferol loss from peritoneal fluid during peritonitis in patients treated with continuous ambulatory peritoneal dialysis.
    Lin CY; Huang TP
    Nephron; 1991; 59(1):90-5. PubMed ID: 1944754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minerals and bone-modulating hormones in children on continuous ambulatory peritoneal dialysis.
    Freundlich M; Zilleruelo G; Abitbol C; Hwang KH; Bourgoignie JJ; Strauss J
    Nephron; 1985; 41(3):267-72. PubMed ID: 3840576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced expression of TGF-beta 1 by peritoneal macrophages in CAPD patients.
    Wang T; Ghen YG; Ye RG; Mai WY; Zhen ZH; Li HQ
    Adv Perit Dial; 1995; 11():11-4. PubMed ID: 8534680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of 25-hydroxyvitamin D and vitamin D binding protein losses in thirteen children on continuous ambulatory peritoneal dialysis.
    Guillot M; Garabedian M; Lavocat C; Guillozo H; Gagnadoux MF; Balsan S; Broyer M
    Int J Pediatr Nephrol; 1983 Jun; 4(2):99-102. PubMed ID: 6688610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD40 ligand expression on macrophages during peritonitis in continuous ambulatory peritoneal dialysis patients.
    Yang X; Ye RG; Kong QY; Yang QQ; Gao Y; Zhong JH; Wang T
    Adv Perit Dial; 2000; 16():213-5. PubMed ID: 11045296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced glycation end products stimulate tumor necrosis factor-alpha and interleukin-1 beta secretion by peritoneal macrophages in patients on continuous ambulatory peritoneal dialysis.
    Rashid G; Korzets Z; Bernheim J
    Isr Med Assoc J; 2006 Jan; 8(1):36-9. PubMed ID: 16450750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of vitamin D on the humoral and cellular immune response and functional activity of peritoneal macrophages].
    Pletsityĭ KD; Davydova TV; Fomina VG; Nikushkin EV
    Biull Eksp Biol Med; 1997 Jan; 123(1):63-5. PubMed ID: 9213462
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of calcifediol treatment on the progression of renal osteodystrophy during continuous ambulatory peritoneal dialysis.
    Buccianti G; Bianchi ML; Valenti G; Lorenz M; Cresseri D
    Nephron; 1990; 56(4):353-6. PubMed ID: 2079992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Losses of calcitriol to peritoneal dialysis bags and tubing.
    Vieth R; Ledermann SE; Kooh SW; Balfe JW
    Perit Dial Int; 1989; 9(4):277-80. PubMed ID: 2488381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peritoneal host defense mechanisms in peritoneal dialysis.
    Holmes CJ
    Kidney Int Suppl; 1994 Dec; 48():S58-70. PubMed ID: 7700043
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.